$bntx
Pfizer has fully exited its stake in BioNTech ($BNTX) for $167M, a significant shift from its former top portfolio position. This news comes amidst broader biotech market volatility and discussions comparing BNTX to competitors like Moderna.
About $bntx
BNTX is a biotechnology company focused on developing innovative therapies.
Insights
- $bntx sentiment is up 100% from the previous week.
- $bntx engagements is up 8576.74% from the previous week.
Engagements: [---] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [------]
[--] Week: [-----] +8,577%
[--] Month: [------] -51%
[--] Months: [---------] -73%
[--] Year: [---------] +2%
1-Year High: [-------] on 2025-03-12
1-Year Low: [---] on 2026-02-08
Engagements by network (24h): X: [---] YouTube: [--] Reddit: [--]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [---]
[--] Month: [---] +85%
1-Year High: [---] on 2026-01-10
1-Year Low: [--] on 2025-12-07
Mentions by network (24h): X: [--] YouTube: [--] Reddit: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $bntx in the last [--] hours which is down 29% from [--] in the previous [--] hours
Daily Average: [--]
[--] Month: [---] +87%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-12-07
The most influential creators that mention $bntx in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @anita37992698 | [--] | [---] | [--] | [--] |
| @BuyTheUgly | [--] | [--] | [--] | [--] |
| @Iam__Mouni | [--] | [---] | [--] | [--] |
Sentiment: 43%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 43%
Daily Average: 75%
[--] Week: 100% +50%
[--] Month: 29% -48%
[--] Months: 29% -27%
[--] Year: 29% -31%
1-Year High: 100% on 2025-02-27
1-Year Low: 12% on 2026-02-08
Most Supportive Themes:
- Positive Comparison to Moderna: (30%) BNTX is highlighted as a company with a multi-modality approach that is outperforming Moderna's mRNA-focused pipeline.
- Potential Investment Opportunity: (25%) BNTX is suggested as a better investment choice compared to MRNA due to perceived administrative headwinds affecting MRNA.
Most Critical Themes:
- Concerns Regarding Claudin-6 Therapy: (15%) There are potential negative implications for Daiichi Sankyo's Claudin-6 therapy, which may indirectly affect related companies like BNTX.
Top $bntx Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"China biotech licensing boom to hit record in [----] as pipeline swells. $MDGL $MRK $GSK $BNTX $SMMT $VSTM $PFE $AZN $NVS $RHHBY https://www.reuters.com/sustainability/climate-energy/china-biotech-licensing-boom-hit-record-2026-pipeline-swells-2026-02-13/ https://www.reuters.com/sustainability/climate-energy/china-biotech-licensing-boom-hit-record-2026-pipeline-swells-2026-02-13/"
X Link @doepke_michel 2026-02-15T10:08Z [----] followers, [----] engagements
"Pfizer $PFE just fully exited BioNTech $BNTX in Q4 [----]. This used to be the #1 position in its portfolio. 100% stake sold $167M exited -37.4ppt portfolio impact From flagship pandemic partner to zero allocation"
X Link @gainify_io 2026-02-13T13:00Z 12.3K followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing